Table 2

Cardiac structure and function parameters according to number of features of metabolic syndrome, adjusted for age and gender.


Number of features of the metabolic syndrome





0
1
2
3
4–5
p (trend)

n = 94
n = 229
n = 226
n = 79
n = 56


Adjusted prevalence (95%CI)






Stage C of heart failure
2.4 (0.6–9.2)
4.0 (2.2–7.3)
4.7 (2.7–8.3)
8.1 (4.0–15.7)
10.5 (5.1–20.5)
0.007
LVSD
0.0 (0.0-0.0)
2.7 (1.3–5.6)
3.0 (1.5–6.0)
2.7 (0.8–8.5)
7.1 (2.9–16.6)
0.02
Diastolic dysfunction
20.8 (13.4–30.6)
23.9 (18.7–30.1)
25.7 (20.3–32.0)
30.2 (20.9–41.6)
36.0 (24.1–49.9)
0.03
Coronary heart disease
3.6 (1.2–10.6)
6.5 (4.0–10.5)
8.1 (5.2–12.4)
10.0 (5.2–18.6)
18.4 (10.3–30.7)
0.002

Adjusted mean (95%CI)






LV diameter/height (mm/m)
29.4 (28.8–30.0)
29.7 (29.3–30.1)
29.9 (29.5–30.3)
29.9 (29.2–30.6)
30.9 (30.1–31.6)
0.008
LV mass/height (g/m)
100.1 (93.5–106.8)
109.0 (104.8–113.3)
113.8 (109.7–118.0)
120.0 (112.8–127.2)
129.9 (121.3–138.5)
< 0.001
LV mass/height2.7 (g/m2.7)
45.9 (42.8–49.1)
49.7 (47.7–51.7)
52.1 (50.1–54.1)
54.5 (51.1–58.0)
59.4 (55.3–63.4)
< 0.001
LV mass/FFM (g/kg)
3.66 (3.44–3.89)
3.92 (3.78–4.07)
3.97 (3.82–4.11)
4.08 (3.83–4.33)
4.39 (4.09–4.68)
< 0.001
Posterior wall/height (mm/m)
5.3 (5.2–5.5)
5.5 (5.4–5.6)
5.6 (5.5–5.7)
5.8 (5.6–6.0)
5.8 (5.6–6.1)
< 0.001
Interventricular septum/height (mm/m)
5.8 (5.6–6.0)
6.1 (5.9–6.2)
6.2 (6.1–6.4)
6.4 (6.2–6.6)
6.6 (6.4–6.9)
< 0.001
Relative wall thickness
0.37 (0.35–0.38)
0.38 (0.37–0.38)
0.38 (0.37–0.39)
0.39 (0.37–0.40)
0.38 (0.36–0.40)
0.05
Left atrium/height (mm/m)
22.0 (21.4–22.6)
22.3 (22.0–22.7)
23.5 (23.1–23.8)
23.5 (22.9–24.1)
24.1 (23.4–24.8)
< 0.001
E wave/A wave (peak velocity)
1.06 (1.00–1.12)
1.04 (1.00–1.08)
0.97 (0.93–1.01)
0.91 (0.85–0.98)
0.94 (0.86–1.02)
< 0.001

CI, confidence interval; LVSD, left ventricular systolic dysfunction; LV, left ventricle; FFM, fat-free mass.

Azevedo et al. BMC Cardiovascular Disorders 2007 7:17   doi:10.1186/1471-2261-7-17